Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

Market Cap	4.98B +7.9%
Revenue (ttm)	4.19B +49.1%
Net Income	200.30M -25.4%
EPS	0.66 -7.0%
Shares Out	296.60M
PE Ratio	25.44
Forward PE	10.11
Dividend	0.50 (2.94%)
Ex-Dividend Date	Sep 29, 2025

Volume	7,983,622
Average Volume	7,100,691
Open	16.79
Previous Close	16.79
Day's Range	16.58 - 17.13
52-Week Range	13.90 - 20.20
Beta	0.62
RSI	66.96
Earnings Date	Apr 24, 2026

About SHA:605077

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltitol a bulk sweetener produced from naturally occurring compounds in corn; erythritol, is produced by the enzymatic hydrolysis of starch into glucose, non...

• Industry: Chemicals
• Sector: Materials
• Founded: 2001
• Employees: 1,350
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 605077

Financial Performance

In 2025, SHA:605077's revenue was 4.19 billion, an increase of 49.15% compared to the previous year's 2.81 billion. Earnings were 200.30 million, a decrease of -25.40%.